Current portfolio

T-Knife

T-knife is a biopharmaceutical company dedicated to developing novel therapeutics to fight cancer, initially focused on T cell receptor (TCR)

  • Sector
    Healthcare
  • Country
    Germany
  • Fund
    LSP 6
  • Entry
    2021
  • Web
T-Knife
0
EQT logo